Physicians may want to consider prescribing antibiotics other than azithromycin and levofloxacin to older patients, based on the findings of a study published in the March/April issue of Annals of Family Medicine. Researchers found that both antibiotics increase the risk of mortality and arrhythmia during different time frames.

Creating the best cardiac cath lab procedure report is the first step to bettering patient care and maximizing reimbursement in this competitive and complex zone.

With cardiovascular disease being the No. 1 killer of Americans and type 2 diabetes one of its most common comorbidities, a number of clinics see coordinated, comprehensive care as a way to treat both conditions.

Biodegradable stents overcome some problems associated with other drug-eluting stents (DES), but advancements in newer durable polymers may give them a run for the money. 

The late-breaking clinical trials at the American College of Cardiology (ACC) scientific sessions often draw large crowds.

Cardiovascular Systems, Inc. (NASDAQ: CSII) (CSI), announced today it has received FDA clearance of its new Diamondback 360®60cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

Patients with heart failure who receive therapy consisting of an implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) have fewer hospitalizations than heart failure patients with only an ICD. The findings, published online March 7 in Circulation, were based on data from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).

Transcatheter aortic valve replacement (TAVR) patients who are inoperable because of technical reasons have better outcomes than TAVR patients who are clinically inoperable, a finding that could help identify patients likely to reap the greatest benefit from the procedure.